In today's fast changing world, synchronisation has become an essential and sensible act to keep the pace with the international market. In the wake of declining efficiency, escalating pricing pressure, meltdowns in profits and sharper focus on improving operational efficiencies, the international pharmaceutical community finds it wise to move towards cost containment through acquisitions, mergers and collaborations. As globalization and outsourcing increase, the lean and thin companies who are sharply focused on their core business have started looking for outsourcing for their core as well as non-core business such as extended manufacturing and R&D support bases; on very cost-effective terms. Developing and emerging economies like India and China have emerged as the outsourcing hub for such multinational pharma companies.
展开▼
